# Clinical Trial of TB511 in Advanced Solid Tumors

> **NCT06400160** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Twinpig Biolab, Inc.** · enrollment: 12 (estimated)

## Conditions studied

- NSCLC
- Prostate Cancer
- Colorectal Cancer
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** TB511
- **DRUG:** Keytruda

## Key facts

- **NCT ID:** NCT06400160
- **Lead sponsor:** Twinpig Biolab, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2028-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400160, "Clinical Trial of TB511 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06400160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*